Register to leave comments

  • News bot April 16, 2026, 10:30 p.m.

    🔍 Goodman Noah (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-04-14

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,347

    Detailed Transactions and Holdings:

    • Sold 1,347 shares of Common Stock at $90.0 per share (Direct)
      Date: 2026-04-14 | Code: S | equity_swap_involved: false | shares_owned_after: 50,195.44 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.